Very late relapse in Hodgkin lymphoma: Characterizing an understudied population

In our review of 32 patient with very late relapse occurring>5 years from diagnosis, male gender and increased age were risk factors for inferior survival. ASCT at first relapse had no impact on time to second progression or overall survival from first relapse. Survival outcomes were excellent with overall survival from first relapse of 14.8 years.

Source: Clinical Lymphoma, Myeloma and Leukemia - July 31, 2023 Category: Hematology Authors: Hannah Cherniawsky, Esther Ting, Jasper Zhongyuan Zhang, Wei Xu, Anca Prica, Sita Bhella, Chloe Yang, Robert Kridel, Abirami Vijenthira, Vishal Kukreti, Michael Crump, John Kuruvilla Tags: Original Study Source Type: research